March 27, 2024 | Boston
From May 13 to 17, Swissnex will host 10 Swiss startups in Boston as part of Venture Leaders Biotech 2024. During the weeklong program, the members of the “Swiss National Startup Team” will exchange with key investors, business leaders, and experts in the area’s life sciences sector.
Throughout the week, the Venture Leaders will explore the world’s leading life sciences hub, pitching to investors and VCs, learning about the specifics of the US business environment from entrepreneurs with extensive experience in the Boston ecosystem, and making connections that can facilitate market entry.
The Venture Leaders Biotech 2024 are:
- Adoram Therapeutics | Leveraging allosteric biochemistry to create new treatments for solid tumors and immune-based diseases
- Allegria Therapeutics | Therapeutics for people suffering from allergy and inflammatory disease associated with mast cell dysfunction
- EVIIVE | A next-generation liquid biopsy solution
- inSEIT | Enzyme immobilization for green industrial production
- KYLYS AESTHETICS | Revolutionizing skin filling science
- OBaris | Providing a painless alternative to injectables
- Shape Biopharmaceuticals | Leveraging computational antigen design and nanoparticle engineering to create a new class of immunotherapeutic drugs
- TissueLabs | A platform for creating organs and tissues in the lab
- Well Science | Changing the course of respiratory allergies through novel combinations of natural ingredients
- Ymmunobio | Developing first in class oncology drugs to address current unmet needs in GI cancers
Members of recent Venture Leaders Biotech cohorts have achieved success in Boston. Last year, Alentis, a participant in the fall 2022 roadshow, closed a $105 million Series C funding round with participation by RA Capital Management, a Boston-based multi-stage investment manager focused on healthcare and life sciences. Also in 2023, Bionomous, another participant in the fall 2022 roadshow, closed a $2.7 million Series A funding round with participation by Cybernetix Ventures, a Boston-based venture capital firm focused on robotics.
Venture Leaders Biotech is organized by Venturelab in partnership with Swissnex in Boston and supported by Debiopharm, EPFL, ETH Zurich, Hansjörg Wyss, Kellerhals Carrard, Novartis, Swiss Biotech Association, and VISCHER.